tiprankstipranks
Trending News
More News >
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market

Aridis Pharmaceuticals (ARDS) Ratios

Compare
207 Followers

Aridis Pharmaceuticals Ratios

ARDS's free cash flow for Q3 2023 was $1.00. For the 2023 fiscal year, ARDS's free cash flow was decreased by $ and operating cash flow was $-2.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.32 0.80 0.67 1.45-
Quick Ratio
0.32 0.81 0.69 1.47-
Cash Ratio
0.13 0.60 0.37 1.08-
Solvency Ratio
-0.78 -1.05 -0.91 -1.18-
Operating Cash Flow Ratio
-0.79 -0.69 -0.91 -0.42-
Short-Term Operating Cash Flow Coverage
-6.77 -32.95 -46.64 0.00-
Net Current Asset Value
$ -27.30M$ -14.11M$ -8.68M$ 3.64M-
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.22 0.05 0.00-
Debt-to-Equity Ratio
-0.25 -0.42 -0.08 0.00-
Debt-to-Capital Ratio
-0.34 -0.74 -0.09 0.00-
Long-Term Debt-to-Capital Ratio
0.00 -0.60 -0.03 0.00-
Financial Leverage Ratio
-0.61 -1.90 -1.74 7.69-
Debt Service Coverage Ratio
-6.39 -96.50 -49.32 0.00-
Interest Coverage Ratio
-79.35 178.41 0.00 0.00-
Debt to Market Cap
66.53 0.21 0.01 0.00-
Interest Debt Per Share
0.35 0.47 0.08 0.00-
Net Debt to EBITDA
-0.04 0.32 0.34 0.73-
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%100.00%-
EBIT Margin
0.00%0.00%-2240.10%-2846.09%-
EBITDA Margin
0.00%0.00%-2206.40%-2813.01%-
Operating Profit Margin
0.00%0.00%-2240.10%-2846.09%-
Pretax Profit Margin
0.00%0.00%-2233.30%-2904.21%-
Net Profit Margin
0.00%0.00%-2191.90%-2836.20%-
Continuous Operations Profit Margin
0.00%0.00%-2233.30%-2904.21%-
Net Income Per EBT
101.24%97.89%98.15%97.66%-
EBT Per EBIT
101.26%98.81%99.70%102.04%-
Return on Assets (ROA)
-209.25%-157.79%-145.00%-103.64%-
Return on Equity (ROE)
164.69%299.65%252.49%-797.19%-
Return on Capital Employed (ROCE)
135.09%667.14%305.90%-336.81%-
Return on Invested Capital (ROIC)
174.87%1206.66%476.71%-277.40%-
Return on Tangible Assets
-209.49%-157.92%-145.26%-103.76%-
Earnings Yield
-112935.13%-147.63%-39.38%-77.01%-
Efficiency Ratios
Receivables Turnover
0.00 0.00 2.72 2.47-
Payables Turnover
0.00 0.00 0.00 0.00-
Inventory Turnover
0.00 0.00 0.00 0.00-
Fixed Asset Turnover
0.00 0.00 0.79 1.02-
Asset Turnover
0.00 0.00 0.07 0.04-
Working Capital Turnover Ratio
0.00 0.00 1.52 0.07-
Cash Conversion Cycle
0.00 0.00 134.32 147.50-
Days of Sales Outstanding
0.00 0.00 134.32 147.50-
Days of Inventory Outstanding
0.00 0.00 0.00 0.00-
Days of Payables Outstanding
0.00 0.00 0.00 0.00-
Operating Cycle
0.00 0.00 134.32 147.50-
Cash Flow Ratios
Operating Cash Flow Per Share
-1.55 -1.87 -2.23 -0.96-
Free Cash Flow Per Share
-1.56 -1.91 -2.27 -0.99-
CapEx Per Share
<0.01 0.04 0.04 0.02-
Free Cash Flow to Operating Cash Flow
1.00 1.02 1.02 1.02-
Dividend Paid and CapEx Coverage Ratio
-355.21 -4.93 -55.79 -46.89-
Capital Expenditure Coverage Ratio
-355.21 -43.28 -55.79 -46.89-
Operating Cash Flow Coverage Ratio
-4.75 -3.84 -28.64 0.00-
Operating Cash Flow to Sales Ratio
0.00 0.00 -20.48 -7.98-
Free Cash Flow Yield
-45192.78%-81.94%-37.45%-22.14%-
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.68 -2.54 -1.30-
Price-to-Sales (P/S) Ratio
0.00 0.00 55.65 36.83-
Price-to-Book (P/B) Ratio
>-0.01 -2.03 -6.41 10.35-
Price-to-Free Cash Flow (P/FCF) Ratio
>-0.01 -1.22 -2.67 -4.52-
Price-to-Operating Cash Flow Ratio
>-0.01 -1.25 -2.72 -4.61-
Price-to-Earnings Growth (PEG) Ratio
>-0.01 -0.02 0.08 0.03-
Price-to-Fair Value
>-0.01 -2.03 -6.41 10.35-
Enterprise Value Multiple
-0.04 -0.33 -2.18 -0.58-
Enterprise Value
1.32M 14.63M 48.14M 16.74M-
EV to EBITDA
-0.04 -0.33 -2.18 -0.58-
EV to Sales
0.00 0.00 48.14 16.38-
EV to Free Cash Flow
-0.05 -0.62 -2.31 -2.01-
EV to Operating Cash Flow
-0.05 -0.64 -2.35 -2.05-
Tangible Book Value Per Share
-1.29 -1.15 -0.95 0.43-
Shareholders’ Equity Per Share
-1.29 -1.15 -0.95 0.43-
Tax and Other Ratios
Effective Tax Rate
-0.01 0.02 0.02 0.02-
Revenue Per Share
0.00 0.00 0.11 0.12-
Net Income Per Share
-1.64 -3.44 -2.39 -3.43-
Tax Burden
1.01 0.98 0.98 0.98-
Interest Burden
1.01 0.99 1.00 1.02-
Research & Development to Revenue
0.00 0.00 16.96 23.56-
SG&A to Revenue
0.00 0.00 6.45 5.90-
Stock-Based Compensation to Revenue
0.00 0.00 2.13 1.97-
Income Quality
0.96 0.54 0.92 0.27-
Currency in USD